Phathom Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PHAT)

132 filings reported holding PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share as of Q1 2024.
Phathom Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PHAT) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 55.4M shares of 69.6M outstanding shares and own 79.57% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (10.1M shares), Medicxi Ventures Management (Jersey) Ltd (7.46M shares), Carlyle Group Inc. (3.5M shares), Invesco Ltd. (3.16M shares), TAKEDA PHARMACEUTICAL CO LTD (3.15M shares), BlackRock Inc. (2.75M shares), Ensign Peak Advisors, Inc (2.28M shares), VANGUARD GROUP INC (1.98M shares), NEA Management Company, LLC (1.96M shares), and Avidity Partners Management LP (1.74M shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.